Bausch Health Companies | VRX - Current Liabilities


Bausch Health Companies reported $4.54B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Amgen USD 25.5B 547M Jun/2026
ANI Pharmaceuticals USD 239.51M 38.6M Mar/2026
Aurora Cannabis CAD 66.93M 79M Mar/2026
Bausch Health Companies USD 4.54B 14M Jun/2026
Biogen USD 3.92B 918.2M Jun/2026
Bristol-Myers Squibb USD 18.66B 499M Jun/2026
Canopy Growth CAD 158.44M 60.15M Mar/2026
Corcept Therapeutics USD 153.8M 4.62M Jun/2026
Danaher USD 8.1B 645M Jun/2026
Drreddys Laboratories INR 167.57B 165.8B Mar/2026
Eli Lilly USD 47.74B 11.11B Jun/2026
Gilead Sciences USD 11.02B 1.54B Jun/2026
Nektar Therapeutics USD 57.71M 4.17M Mar/2026
Novo Nordisk DKK 239.08B 13.92B Jun/2026
Pacira USD 122.01M 13.22M Jun/2026
Perrigo USD 1.05B 57.2M Jun/2026
Phibro Animal Health USD 281.87M 500K Mar/2026
Prestige Brands USD 120.92M 18.63M Mar/2026
Supernus Pharmaceuticals USD 347.38M 26.55M Jun/2026
Vertex Pharmaceuticals USD 3.94B 57.3M Jun/2026
Zoetis USD 2.05B 182M Mar/2026